Eupraxia Pharmaceuticals Common Stock Price on November 25, 2024
| EPRX Stock | 3.35 0.10 2.90% |
If you're considering investing in Eupraxia Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Eupraxia Pharmaceuticals stands at 3.35, as last reported on the 29th of November, with the highest price reaching 3.63 and the lowest price hitting 3.32 during the day. Eupraxia Pharmaceuticals appears to be very risky, given 3 months investment horizon. Eupraxia Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.11, which denotes the company had a 0.11% return per unit of risk over the last 3 months. By reviewing Eupraxia Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.59% is justified by implied risk. Please utilize Eupraxia Pharmaceuticals' Coefficient Of Variation of 1125.3, mean deviation of 3.81, and Downside Deviation of 4.82 to check if our risk estimates are consistent with your expectations.
Eupraxia Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Eupraxia |
Sharpe Ratio = 0.1078
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | EPRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.5 actual daily | 48 52% of assets are more volatile |
Expected Return
| 0.59 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Eupraxia Pharmaceuticals is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eupraxia Pharmaceuticals by adding it to a well-diversified portfolio.
Related Headline
Enanta Pharmaceuticals Headline on 25th of November 2024
Enanta Pharmaceuticals Inc Reports Q4 Loss of 1.36 Per Share... by gurufocus.com
Revenue 14.6 million for the quarter, below the estimated 17.93 million, reflecting a decline from 18.9 million in the same period last year.Net Loss 28.
Eupraxia Pharmaceuticals Valuation on November 25, 2024
It is possible to determine the worth of Eupraxia Pharmaceuticals on a given historical date. On November 25, 2024 Eupraxia was worth 3.41 at the beginning of the trading date compared to the closed value of 3.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eupraxia Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Eupraxia Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eupraxia Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eupraxia Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 3.49 | 3.49 | 3.27 | 3.49 | 26,383 | |
11/25/2024 | 3.41 | 3.52 | 3.41 | 3.41 | 7,030 |
| 3.40 | 3.46 | 3.05 | 3.05 | 14,831 |
| Backtest Eupraxia Pharmaceuticals | | | Eupraxia Pharmaceuticals History | Previous | Next |
Eupraxia Pharmaceuticals Trading Date Momentum on November 25, 2024
| On November 26 2024 Eupraxia Pharmaceuticals Common was traded for 3.05 at the closing time. The top price for the day was 3.46 and the lowest listed price was 3.05 . The trading volume for the day was 14.8 K. The trading history from November 26, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 10.56% . The overall trading delta against the current closing price is 5.57% . |
Price Boundaries
Eupraxia Pharmaceuticals Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Eupraxia Pharmaceuticals Common cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Eupraxia Pharmaceuticals November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Eupraxia Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eupraxia Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eupraxia Pharmaceuticals pink sheet market strength indicators, traders can identify Eupraxia Pharmaceuticals Common entry and exit signals to maximize returns
Eupraxia Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eupraxia Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eupraxia Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eupraxia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0767 | |||
| Jensen Alpha | 0.5793 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0745 | |||
| Treynor Ratio | (0.52) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Eupraxia Pink Sheet Analysis
When running Eupraxia Pharmaceuticals' price analysis, check to measure Eupraxia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eupraxia Pharmaceuticals is operating at the current time. Most of Eupraxia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eupraxia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eupraxia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eupraxia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.